Risk Project
The Risk Project intends to answer the one question that plagues most all patients: Why did this happen to me? CERN is expanding the work of our successful Ependymoma Outcomes Surveys to improve our understanding of risk factors associated with the occurrence of ependymoma. Sign up today!
Referrals
Connecting you with neuro-oncologists who specialize in treating ependymoma.
Where to Start
-
Ependymoma Basics
If you or a loved one has just been diagnosed, we are here to help you get the facts on ependymoma. Learn More
-
Support
Ways you can help care for yourself or a loved one during and after ependymoma treatment. Learn More
-
Diagnosis
Learn how ependymoma is diagnosed, what it looks like and what to do after being diagnosed. Learn More
-
Resources
Find resources from other patients and caregivers and experts in the medical community. Learn More
-
Treatment
To make the best ependymoma treatment decisions, you need to understand all of your options. Learn More
-
Get Involved
Ways you can help us expand our understanding of ependymoma, raise additional funding, or create more awareness of ependymoma. Learn More
“When I was first diagnosed six years ago - my life was turned upside down. I contacted the CERN Foundation and they were so kind and genuinely interested in providing information and direction. With their help, I was able to find a medical center experienced in treating ependymoma.”
CERN Headlines
CERN Foundation Releases Ependymoma Community Blog Series
This series of blog articles is written by members of the ependymoma community. Some are ependymoma survivors and others are caregivers. They share their advice to help others with ependymoma cope with their illness.
- Jan13
Survivorship: What’s Next?
Adam Holland writes about his experience moving forward after his diagnosis with ependymoma. He reflects on all that he has gone through and provides insight into the process of accepting his new normal. In this blog article, Adam reminds us all of the power of telling our story. - Dec11
CERN 08-02 Clinical Trial Creates Significant Impact in the Ependymoma Community
The CERN Foundation supported a phase II clinical trial, CERN 08-02, for adults with recurrent ependymoma. A manuscript describing the results of the trial has been accepted for publication in Neuro-Oncology. Neuro-Oncology is the official journal of the Society for Neuro-Oncology. - Sep17
CERN Foundation to Become A Designated Program of NBTS
National Brain Tumor Society (NBTS) and the CERN Foundation Announce Official Plans for CERN to Become a Designated Program of the NBTS